Holley Performance Brands (NYSE:HLLY), Virgin Galactic (NYSE:SPCE) and Encompass Health (NYSE:EHC): Three Announcements to Know

Sonal Goyal

28 October 2026 12:12 AM AEDT

Holley Performance Brands (NYSE:HLLY), Virgin Galactic (NYSE:SPCE) and Encompass Health (NYSE:EHC): Three Announcements to Know

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Holley and Amotiv announced a collaboration beginning with Flowmaster Engineered by Ryco oil filters.
Virgin Galactic's lead Spaceship is set to fly to Spaceport America on October 28.
Virgin Galactic now expects the lead Spaceship's first commercial spaceflight in early Q2 2027.
Encompass Health plans a 24-bed hospital in Richmond, Texas, expected to open in 2028.

Three U.S.-listed companies made announcements on October 26, 2026. Holley Performance Brands (NYSE:HLLY) outlined a collaboration with Amotiv Limited, Virgin Galactic (NYSE:SPCE) gave details of its lead Spaceship's move to its operations base, and Encompass Health Corp. (NYSE:EHC) announced a new inpatient rehabilitation hospital project in Texas.

Holley and Amotiv Collaboration

Holley and Amotiv Limited (ASX: AOV) announced a strategic collaboration to expand the reach of their brands across North America, Australia and New Zealand. The first step is Flowmaster Engineered by Ryco Performance Oil Filters, which uses Ryco's SynTec technology and marks Flowmaster's entry into filtration. The companies are evaluating further opportunities for 2027 and beyond, including Amotiv's DBA brake and XClutch products in Holley's North American channels, subject to further evaluation and approvals. A joint press conference is planned at the SEMA Show in Las Vegas on November 3.

Virgin Galactic Spaceship Arrival

Virgin Galactic said its lead Spaceship will fly to Spaceport America, New Mexico, on October 28, departing the Spaceship Factory in Mesa, Arizona. The Spaceship's name, chosen by public vote, will be announced that day. The company now expects the lead Spaceship's first commercial spaceflight in early Q2 2027 and the second Spaceship's commercial operations in late Q2 or early Q3 2027, citing additional time for avionics software integration and validation. More than 100 members of its astronaut community are entering their first phase of readiness.

Encompass Health Richmond Hospital

Encompass Health plans a 24-bed small-format inpatient rehabilitation hospital in Richmond, Texas, expected to open in 2028. It will operate as a satellite of Encompass Health Rehabilitation Hospital of Sugar Land and is the company's second small-format project serving the greater Houston area, after one in Conroe. The hospital will serve patients recovering from stroke, neurological conditions, brain and spinal cord injuries, amputations and complex orthopedic conditions.

Why This Could Matter

Each release ties its news to a stated plan. Holley said the collaboration supports its strategy of extending its brands into adjacent product categories. Virgin Galactic said it will give more detail on flight tests and its financial outlook on its third quarter earnings call in November. Encompass Health, which describes a footprint of 179 hospitals in 39 states and Puerto Rico, linked the Richmond project to serving communities closer to home using the resources of established hospitals.

Final Perspective

The announcements cover a product collaboration at Holley, updated commercial spaceflight timing at Virgin Galactic and a planned 2028 hospital opening at Encompass Health, each framed around the company's own stated plans and timetable.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.